logo
SPY Attracts $1.8B as S 500 Edges Higher on Tariff Hopes

SPY Attracts $1.8B as S 500 Edges Higher on Tariff Hopes

Yahoo5 days ago
The SPDR S&P 500 ETF Trust (SPY) pulled in $1.8 billion Monday, bringing its assets under management to $641.2 billion, according to data provided by FactSet. The inflows came as the S&P 500 added 0.1% and the Nasdaq Composite rose 0.3% despite President Donald Trump announcing 30% tariffs on the European Union and Mexico over the weekend.
The iShares Bitcoin Trust ETF (IBIT) attracted $953.5 million as Bitcoin reached fresh records above $123,000, while the iShares Core MSCI EAFE ETF (IEFA) collected $647.3 million. The iShares Broad USD High Yield Corporate Bond ETF (USHY) gained $371.7 million, and the iShares Core S&P 500 ETF (IVV) pulled in $313.4 million.
The Invesco QQQ Trust (QQQ) saw outflows of $1.5 billion, while the iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) lost $432.1 million. The Health Care Select Sector SPDR Fund (XLV) experienced outflows of $351.5 million.
U.S. equity ETFs attracted $1.4 billion for the day, while U.S. fixed-income ETFs gained $803.9 million. International equity ETFs pulled in $1.1 billion. Overall, ETFs collected $5.3 billion for the day.
Ticker
Name
Net Flows ($, mm)
AUM ($, mm)
AUM % Change
SPY
SPDR S&P 500 ETF Trust
1,777.93
641,229.28
0.28%
IBIT
iShares Bitcoin Trust ETF
953.52
84,196.73
1.13%
IEFA
iShares Core MSCI EAFE ETF
647.25
142,694.30
0.45%
USHY
iShares Broad USD High Yield Corporate Bond ETF
371.73
24,630.90
1.51%
IVV
iShares Core S&P 500 ETF
313.41
630,958.78
0.05%
IWM
iShares Russell 2000 ETF
255.10
66,659.08
0.38%
SLV
iShares Silver Trust
250.41
18,040.07
1.39%
AVDV
Avantis International Small Cap Value ETF
242.06
10,464.45
2.31%
VCSH
Vanguard Short-Term Corporate Bond ETF
214.31
34,505.48
0.62%
GQGU
GQG US Equity ETF
202.11
202.11
100.00%
Ticker
Name
Net Flows ($, mm)
AUM ($, mm)
AUM % Change
QQQ
Invesco QQQ Trust Series I
-1,524.43
351,838.33
-0.43%
LQD
iShares iBoxx $ Investment Grade Corporate Bond ETF
-432.12
28,725.50
-1.50%
XLV
Health Care Select Sector SPDR Fund
-351.48
33,629.54
-1.05%
VB
Vanguard Small-Cap ETF
-338.86
64,405.89
-0.53%
VWOB
Vanguard Emerging Markets Government Bond ETF
-323.90
4,890.68
-6.62%
TLT
iShares 20+ Year Treasury Bond ETF
-291.45
47,077.40
-0.62%
DIA
SPDR Dow Jones Industrial Average ETF Trust
-177.50
38,204.78
-0.46%
SMH
VanEck Semiconductor ETF
-129.40
27,444.53
-0.47%
ARKK
ARK Innovation ETF
-119.32
6,942.24
-1.72%
SOXL
Direxion Daily Semiconductor Bull 3x Shares
-102.18
14,231.11
-0.72%
Net Flows ($, mm)
AUM ($, mm)
% of AUM
Alternatives
2.04
10,229.01
0.02%
Asset Allocation
7.97
25,245.31
0.03%
Commodities ETFs
492.98
223,765.76
0.22%
Currency
1,233.05
171,287.33
0.72%
International Equity
1,064.22
1,888,846.27
0.06%
International Fixed Income
577.16
306,168.02
0.19%
Inverse
100.99
14,181.49
0.71%
Leveraged
-417.35
145,610.96
-0.29%
US Equity
1,387.92
7,215,245.58
0.02%
US Fixed Income
803.85
1,702,397.59
0.05%
Total:
5,252.83
11,702,977.33
0.04%
Disclaimer: All data as of 6 a.m. Eastern time the date the article is published. Data are believed to be accurate; however, transient market data are often subject to subsequent revision and correction by the exchanges.Permalink | © Copyright 2025 etf.com. All rights reserved
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

History suggests stocks could have more upside, says analyst
History suggests stocks could have more upside, says analyst

Miami Herald

time43 minutes ago

  • Miami Herald

History suggests stocks could have more upside, says analyst

There weren't many beating the bullish drum on the stock market in early April. The S&P 500 and tech-laden Nasdaq Composite were mired in a brutal downturn following harsher-than-hoped tariff announcements and growing economic concerns on jobs and inflation. The S&P 500 retreated 19% from its mid-February highs before finding its footing on April 9. That near-bear market had everyone a bit antsy, particularly given President Donald Trump's mounting trade war. Nevertheless, stocks' decline was fast and steep enough to cause most sentiment measures to signal oversold, suggesting that those willing to step into the fray could be rewarded for buying the dip. And boy, have they been rewarded. Don't miss the move: Subscribe to TheStreet's free daily newsletter The S&P 500 has marched 25% higher, and the Nasdaq has surged over 30%. President Trump's pause on most reciprocal tariffs fueled the gains on April 9. Hope that tariffs would settle at more manageable levels and significant new stimulus associated with trillions of dollars in tax cuts from the One Big Beautiful Bill Act kept the rally humming along to new all-time highs. The big question on most minds now is whether this record-setting run can continue. Those in the bearish camp point toward weaker GDP, cracks in the jobs market, and inflation risks. Bullish investors think most of those risks were priced in during the spring sell-off, and the bar has been set low enough that anything less than disaster would be good enough to push forward revenue, earnings, and economic outlooks higher, rather than lower. The debate has prompted many popular Wall Street analysts, including Carson Group's Chief Strategist Ryan Detrick, to update their outlook. Image source: Michael M. Santiago/Getty Images Stocks are forward-looking and are considered a leading, rather than lagging, indicator. The ability of stock prices to predict what may happen to the economy can be messy, with short-term fits and starts. However, stocks' ability to aggregate market participants' collective wisdom is generally considered a valuable tool for economists and investors. Related: Market legend makes surprising stock market bet The predictive nature of markets is one reason behind the old Wall Street adage, "stocks climb a wall of worry." Often, stocks bottom when everyone thinks the worst has yet to happen, and they top when everyone sees roses and daisies. Over the past three months, the stock market has climbed a big wall of concern. U.S. employers have announced over 696,000 layoffs through May, up 80% year over year, according to Challenger, Gray & Christmas. The unemployment rate has inched up to 4.1% in June from 3.4% in 2023. And inflation, while much lower than in 2022, when the Federal Reserve declared war on it by significantly raising interest rates, is still above the 2% level targeted by many, including the Fed. The backdrop still suggests that stagflation or, worse, recession is a possibility. But so far, stocks indicate the economy will sidestep most damage. While we don't know when the Fed may support the economy with interest rate cuts, most are modeling lower rates over the coming year, helping fuel economic activity. Also, the recently passed One Big Beautiful Bill Act contains significant tax cuts, including new Social Security income tax breaks and a higher State and Local Tax deduction, which provide additional money to support spending and GDP. If so, analysts who cut revenue and growth outlooks this spring will shift gears, increasing forecasts and potentially fueling additional upside. Those upward revisions would go a long way toward appeasing those concerned about the S&P 500's valuation, given that the recent rally has inflated its price-to-earnings (P/E) ratio. The S&P 500 topped out in February when its forward price-to-earnings ratio eclipsed 22. It bottomed out when the P/E ratio reached about 19. The recent rally has again pushed the S&P 500's P/E over 22, which historically doesn't correspond with favorable one-year returns. Ryan Detrick has been correctly banging the bullish drum for a while, and his team's midyear outlook also tells a bullish tale. Detrick's optimism is partially rooted in history. He often shares data highlighting how the stock market has historically behaved after catalysts, and this time is no exception. Fortunately, for bulls, history is on the side of more gains. The strategist points out that since the early 1970s, there have been five instances when the S&P 500 rose by 19% in 27 trading days like this year. Each time, the market was higher one year later, returning a median of 32.6%. Since 1950, the S&P 500 has been up one year later 74% of the time, returning a median of 10.4%. Related: Billionaire Ackman has one-word message on stock market We've already made a big chunk of returns, but Detrick's team writes, "This is still a young bull market." The average bull market lasts 67 months, and this one has only lasted a little over 30 months so far. "Like a cruise ship that is very hard to turn once it gets moving, bull markets tend to carry their momentum forward, another reason this one could last much longer than many think," wrote the analysts. As for valuation, they believe there's a bull case that a "low tariffs, big tax bill" environment will provide a catalyst for earnings, helping keep the P/E ratio in check. "It's hard to imagine that the tariffs will go back to where they were, but perhaps we're left with about 15% additional new tariffs on average- not at all trivial, but far from worst case," wrote the analysts. "Companies should be able to navigate the additional tariffs and maintain profit margins, especially larger companies with less fragile supply chains." Carson Group thinks the S&P 500 could reach 6,550, a 10% to 12% gain for 2025. Add in dividends, and the index's total return could be 12% to 15%. Currently, the S&P 500 is up about 7% in 2025. "Stocks came soaring back in one of the largest reversals ever, suggesting the lows for 2025 are likely behind us and better times could be coming for investors," said Detrick. "While 2025 has already been a wild ride - and we should still prepare for more ups and downs - we see reasons to expect this bull market to continue." Related: Legendary fund manager has blunt message on 'Big Beautiful Bill' The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

House Republicans tiptoe toward tariff criticism
House Republicans tiptoe toward tariff criticism

Yahoo

timean hour ago

  • Yahoo

House Republicans tiptoe toward tariff criticism

President Donald Trump's determination to barrel ahead with tariffs is forcing a growing number of Republican lawmakers to make an uncomfortable choice: defend the president's agenda or influential industries back home. So far, they are trying to thread the needle by expressing concerns to administration officials couched in praise for the president — but not yet supporting legislation to rein in his trade authority. The gentle, behind-the-scenes pushback, primarily in the form of group letters, is a sign of the squeeze Trump's trade agenda is putting on some Republicans, who face pressure from powerful, export-reliant industries like aerospace and agriculture, but also fear crossing a president known for nursing grudges. In recent weeks, dozens of House Republicans have signed onto letters to Trump's top trade advisers encouraging them to take a restrained approach to future tariffs — in particular, the industry-specific tariffs the Commerce Department is weighing on sectors ranging from semiconductors to pharmaceuticals to drones. Trump has hinted that some of those duties will be rolled out soon, telling reporters on Tuesday that tariffs on pharmaceuticals could be coming 'at the end of the month,' starting at a low rate but gradually rising to a 'very high tariff.' That effort is being driven in part by industry groups representing a broad range of critical sectors that depend on trade and exports, that have concluded that direct appeals to the administration carry less weight than channeling their lobbying through Congress. The lawmakers' letters are always laudatory. 'We write to commend this Administration's commitment to restore a robust American manufacturing sector,' read a June 17 letter from two dozen House Republicans — many representing swing districts — that was shared with POLITICO. But the underlying request is clear: rein in the tariffs. The June letter, which was led by Rep. Ron Estes, went on to urge U.S. Trade Representative Jamieson Greer to honor a longstanding zero-tariff agreement on civil aircraft between the U.S. and other countries — and, implicitly, drop the administration's plan to raise tariffs on imports of aerospace products. Lawmakers also underscored the industry's trade surplus and 'its high-wage domestic manufacturing workforce' — a subtle counterpoint to Trump's argument that tariffs are necessary to rebalance global trade and return manufacturing to the U.S. Estes' Wichita-based district is home to several aerospace companies, including the headquarters for Spirit Aerosystems, a commercial airline manufacturer. Kansas companies export about $2.3 billion in aerospace products annually, according to the Kansas Department of Commerce, which is 20 percent of the Midwestern state's total exports. 'One of the unique things in the aerospace industry is that since 1979 there's been a zero-zero tariff policy that's out there,' Estes said in an interview. 'And that kind of ties in with the president's objective of 'how do we have growth in America,' because without having some of the constraints around tariffs, America has been very successful in terms of developing and supplying the world.' Estes and a number of his GOP colleagues on the House Ways and Means Committee also signed onto a recent letter urging Commerce Secretary Howard Lutnick to narrow the focus of any future U.S. duties on pharmaceuticals to Chinese-made products, reminding Lutnick that trade disruptions to drugs 'jeopardize the health and lives of Americans that rely on treatment.' 'I feel strongly that we need a targeted approach,' Nicole Malliotakis, the New York Republican who led the letter, said in a recent interview. 'We can't 'make it in America' if we don't have certain parts and components and materials, and so, the first piece of this is to make sure the things we actually need to make in America are available and don't have the tariffs.' Malliotakis' Staten Island-based district is home to a network of independent pharmacies that have long complained about rising drug costs and shrinking profit margins — problems they say would be exacerbated by broad-based tariffs on imported medicines. One of the lobbyists who pitched the letter to Malliotakis and her colleagues said it was the product of outreach from 'local pharmacists, the mom-and-pop shops,' who helped nudge the right-leaning lawmakers into 'understanding the outsized impact of hikes on pharmaceutical tariffs.' The lobbyist was granted anonymity to discuss the details of those private conversations. It's just one example of the quiet but intense effort by business groups to rein in the Trump administration's most potentially damaging duties — particularly those Trump is considering applying on a national security basis. Under existing trade law known as Section 232, the Commerce Department must investigate whether foreign imports of a certain product represents a security threat before the president can take that action. Lutnick is currently overseeing nine investigations of key industries — everything from lumber to copper to semiconductors to drones. A White House official defended the administration's plans to target critical sectors with higher tariffs, arguing there are "very clear national security, national and economic security prerogatives at play." "We all remember back in 2021, 2022 ... we had shortages of critical drugs and medical equipment during Covid," as well as "car shortages because of semiconductor shortages." The administration is approaching the tariffs in "a much more thoughtful way than I think we're being ... given credit for," the official continued. "They're all also hypotheticals, because, again, we have to finish these 232 reports. We haven't unveiled any of these." Industry groups, however, are pulling out all the stops to pressure the administration not to follow through on the most extreme tariff proposals, from filing comments on the investigations, to walking lawmakers through factories that may have to make cuts due to the tariffs, to attempting to secure as many meetings as possible with officials they know have Trump's ear. One pro-trade lobbyist, who pitched a March letter to GOP lawmakers calling for greater agricultural market access, said industry groups are 'focusing their efforts on the members of Congress that they know that have phone call access to the Trump administration.' An official in the U.S. Trade Representative's office confirmed it has been fielding comments from members of Congress and the business community about tariffs' potential impact. 'USTR has been engaged with Congress, stakeholders, and business leaders at an unprecedented pace and will continue to do so,' said the official, who was granted anonymity to speak about meetings that are not open to the public. A spokesperson for the Commerce Department did not immediately respond to POLITICO's request for comment. At the same time, business groups and their allies in Congress are being careful not to appear like they are criticizing Trump or opposing a key plank of his administration. 'There's room in this administration for those differences of opinion about the best way to architect an equal America First trade strategy,' said one right-leaning corporate lobbyist involved with the effort, who recently met with administration officials. 'And if certain approaches are fine-tuned or refined, there's a way to truly protect key segments of manufacturing.' Sen. Steve Daines (R-Mont.) and 11 other Senate Republicans joined with 44 House colleagues to send a letter to Trump's top trade officials thanking them for their work on trade deals, while pushing the administration to continue to expand U.S. agricultural markets. 'They're rooting for the president,' Daines said of his constituents. 'They just want to see [trade deals] done sooner versus later. And the administration is seeing that, I know they've got a full court press on this, going as fast as they can.' Senate Republicans have been forced to vote on Democrat-led resolutions aimed at blocking Trump from pursuing some of his tariffs — and all but a few toed the party line. House Republicans, however, have maneuvered to avoid a similar vote. That has allowed members to maintain that they are firmly in favor of Trump's agenda. 'It is categorically wrong to say we oppose Trump on trade,' said one of the staffers for a Republican lawmaker, granted anonymity to speak candidly. To put it another way, 'It's not our job to publicly shame Trump on his approach to trade,' said a staffer for a different Republican lawmaker. 'It's about Trump understanding the benefits of a more measured approach.' 'We admit there's still work to do,' the staffer added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store